Last reviewed · How we verify
NCT06226935
Comparative Analysis of Glaucoma Screening Uptake Among First-Degree Relatives in Community-Based and Hospital-Based Approaches
trial in Evaluate the Differences in Glaucoma Screening Uptake Among FDRs in Community and Hospital-based in 1,304 participants. Completed in 31 May 2023.
1 December 2022
Quick facts
| Lead sponsor | Phrapokklao Hospital,Thailand |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,304 |
| Start date | 1 January 2022 |
| Primary completion | 1 December 2022 |
| Estimated completion | 31 May 2023 |
| Sites | 1 location across Thailand |
Conditions studied
- Evaluate the Differences in Glaucoma Screening Uptake Among FDRs in Community and Hospital-based — all drugs for Evaluate the Differences in Glaucoma Screening Uptake Among FDRs in Community and Hospital-based →
Sponsor
Phrapokklao Hospital,Thailand
Who can join
40 and older, any sex, with Evaluate the Differences in Glaucoma Screening Uptake Among FDRs in Community and Hospital-based. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In conclusion, the study shows that the hospital-based group had a significantly higher screening uptake than the community-based group, reflecting that information from ophthalmologists and registered ophthalmic nurses is more effective and well-received than that from village health volunteers. The study suggests that increasing education and support for village health volunteers could enhance screening uptake. Factors influencing uptake include the age of FDRs, place of residence, education, presenting VA of probands, and treatment of probands. Utilizing this study's findings, spreading knowledge and training health officials at the district and sub-district levels could increase understanding of glaucoma and improve communication with the general public and at-risk groups, potentially increasing the response rate. Additionally, implementing a national free screening glaucoma program for at-risk populations, both in and outside hospitals, and organizing mobile screening units at the district level could be an effective prevention strategy against permanent vision loss from glaucoma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06226935
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Phrapokklao Hospital,Thailand trials
Trials by the same sponsor.
- NCT06288269 — Factors of Control Hypertension or Type 2 Diabetes on the Severity of Stroke and Survival Rates Within 1 Year in Trat · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06226935 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Phrapokklao Hospital,Thailand
- Last refreshed: 30 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06226935.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing